Orally bioavailable BTK PROTAC active against wild-type and C481 mutant BTKs in human lymphoma CDX mouse models.
Blood Adv
; 7(1): 92-105, 2023 01 10.
Article
in En
| MEDLINE
| ID: mdl-36269842
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidines
/
Lymphoma, Large B-Cell, Diffuse
Limits:
Animals
/
Humans
Language:
En
Journal:
Blood Adv
Year:
2023
Document type:
Article
Country of publication:
Estados Unidos